ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 849,07
-0,35%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) Actualités

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SEEL
DateHeureSourceTitreSymboleSociété
16/05/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
14/05/202414h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202423h32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202422h50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
01/03/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
14/02/202422h50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
06/02/202423h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/202412h04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
30/01/202412h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
02/01/202414h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
28/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
18/12/202322h54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
15/12/202322h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
04/12/202322h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
28/11/202322h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SEELSeelos Therapeutics Inc
29/06/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
12/05/202322h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SEELSeelos Therapeutics Inc
28/04/202312h23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202322h11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202323h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202322h09Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SEELSeelos Therapeutics Inc
13/03/202321h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SEELSeelos Therapeutics Inc
10/03/202312h05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SEELSeelos Therapeutics Inc
09/02/202318h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
08/07/202222h59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SEELSeelos Therapeutics Inc
04/05/202213h35TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Masimo (MASI)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202223h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SEELSeelos Therapeutics Inc
11/03/202218h05TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Leap Therapeutics (LPTX)NASDAQ:SEELSeelos Therapeutics Inc
24/01/202210h50TipRanksB.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to RecoverNASDAQ:SEELSeelos Therapeutics Inc
27/12/202123h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SEELSeelos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SEEL

Dernières Valeurs Consultées

TSX
PLZ.UN
Plaza Retail REIT
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés